Fady Ibraham Malik
Director; EVP Research & Development · 12 filings · Latest: Jul 21, 2026
CYTOKINETICS INC
ROCKET PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CYTK | Fady Ibraham Malik | EVP Research & Development | Jul 21, 2026 | Sale | $80.59 | 3,500 | $282.1K | 153,902 | |
CYTK | Fady Ibraham Malik | EVP Research & Development | Jul 21, 2026 | Option Exercise | $7.80 | 3,500 | $27.3K | 157,402 | |
CYTK | Fady Ibraham Malik | EVP Research & Development | Jul 7, 2026 | Sale | $86.62 | 3,500 | $303.2K | 153,902 | |
CYTK | Fady Ibraham Malik | EVP Research & Development | Jul 7, 2026 | Option Exercise | $7.80 | 3,500 | $27.3K | 157,402 | |
CYTK | FADY MALIK | — | Jul 7, 2026 | Proposed Sale | $85.57 | 24,500 | $2.1M | — | |
RCKT | Malik Fady Ibraham | — | Jul 7, 2026 | Proposed Sale | $3.88 | 10,670 | $41.4K | — | |
CYTK | Fady Ibraham Malik | EVP Research & Development | Jun 23, 2026 | Sale | $79.51 | 3,500 | $278.3K | 153,902 | |
CYTK | Fady Ibraham Malik | EVP Research & Development | Jun 23, 2026 | Option Exercise | $7.80 | 3,500 | $27.3K | 157,402 | |
CYTK | Fady Ibraham Malik | EVP Research & Development | Jun 9, 2026 | Sale | $67.98 | 3,500 | $237.9K | 153,902 | |
CYTK | Fady Ibraham Malik | EVP Research & Development | Jun 9, 2026 | Option Exercise | $7.80 | 3,500 | $27.3K | 157,402 | |
CYTK | Fady Ibraham Malik | EVP Research & Development | May 19, 2026 | Sale | $75.69 | 3,500 | $264.9K | 153,902 | |
CYTK | Fady Ibraham Malik | EVP Research & Development | May 19, 2026 | Option Exercise | $7.80 | 3,500 | $27.3K | 157,402 | |
CYTK | Fady Ibraham Malik | EVP Research & Development | May 5, 2026 | Sale | $77.37 | 3,500 | $270.8K | 153,902 | |
CYTK | Fady Ibraham Malik | EVP Research & Development | May 5, 2026 | Option Exercise | $7.80 | 3,500 | $27.3K | 157,402 | |
CYTK | Fady Ibraham Malik | EVP Research & Development | Apr 21, 2026 | Sale | $65.69 | 3,500 | $229.9K | 153,902 | |
CYTK | Fady Ibraham Malik | EVP Research & Development | Apr 21, 2026 | Option Exercise | $7.80 | 3,500 | $27.3K | 157,402 | |
CYTK | Fady Ibraham Malik | EVP Research & Development | Apr 7, 2026 | Sale | $65.11 | 4,500 | $293.0K | 153,902 | |
CYTK | Fady Ibraham Malik | EVP Research & Development | Apr 7, 2026 | Option Exercise | $8.42 | 4,500 | $37.9K | 154,902 | |
CYTK | FADY MALIK | — | Apr 7, 2026 | Proposed Sale | $64.94 | 22,000 | $1.4M | — | |
CYTK | Fady Ibraham Malik | EVP Research & Development | Mar 17, 2026 | Sale | $62.15 | 12,033 | $747.9K | 153,902 |
Page 1 of 2
Next →